CompaniesABF Pharmaceutical Services

ABF Pharmaceutical Services

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

124

By Phase

PHASE2: 1PHASE1: 1

By Status

TERMINATED: 1COMPLETED: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Today

Hover over trial bars to see details

Recent Trials

NCT04731298Collaborator

Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.

PHASE2Terminated

Started: May 25, 2021 · Completed: Apr 21, 2022

NCT02502903Collaborator

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

PHASE1Completed

122 participants

Started: Jul 13, 2015 · Completed: Mar 31, 2021

Related Companies

Gbf Group Pharma

acquired